Finance

Lists
688566:SHA
Jiangsu Jibeier Pharmaceutical Co Ltd
CNÂ¥26.54
+0.19%
(+0.050) 1D
Oct 16, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688566...
Open
CNÂ¥26.88
High
CNÂ¥26.99
Low
CNÂ¥26.05
Mkt. cap
5.48B
Avg. vol.
1.80M
Volume
2.98M
Dividend
1.96%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jun 25, 2026
P/E ratio
24.96
52-wk high
CNÂ¥35.96
52-wk low
CNÂ¥22.82
EPS
CNÂ¥1.06
No. of employees
1K
Open
CNÂ¥26.88
High
CNÂ¥26.99
Low
CNÂ¥26.05
Mkt. cap
5.48B
Avg. vol.
1.80M
Volume
2.98M
Dividend
1.96%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jun 25, 2026
P/E ratio
24.96
52-wk high
CNÂ¥35.96
52-wk low
CNÂ¥22.82
EPS
CNÂ¥1.06
No. of employees
1K
News stories
From web sources and news partners
About Jiangsu Jibeier Pharmaceutical Co Ltd
CEO-
Employees1.38K
FoundedNov 13, 2001
Headquarters-
SectorPharmaceutical industry
Websitejbepharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
249.52M
261.63M
226.42M
263.14M
Cost of goods sold
26.21M
29.16M
22.30M
26.27M
Cost of revenue
26.21M
29.16M
22.30M
26.27M
Research and development expenses
10.57M
10.48M
9.60M
12.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
157.68M
147.12M
142.63M
153.02M
Operating expense
169.59M
160.70M
153.21M
172.16M
Total operating expenses
195.79M
189.86M
175.52M
198.43M
Operating income
53.73M
71.77M
50.90M
64.71M
Other non operating income
-50.52K
-2.46K
-40.36K
-47.77K
EBT including unusual items
54.32M
73.43M
50.12M
64.57M
EBT excluding unusual items
55.50M
73.32M
51.98M
66.24M
Income tax expense
7.60M
8.30M
9.17M
8.83M
Effective tax rate
13.99%
11.30%
18.30%
13.68%
Other operating expenses
2.68M
4.79M
3.70M
4.61M
Net income
47.59M
64.70M
41.99M
57.24M
Net profit margin
19.07%
24.73%
18.55%
21.75%
Earnings per share
-
-
-
-
Interest and investment income
1.83M
1.63M
1.13M
1.61M
Interest expense
-12.58K
-79.75K
-11.82K
-24.24K
Net interest expenses
1.82M
1.55M
1.12M
1.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
56.38M
76.20M
55.33M
70.37M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps